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Abstract QUALEFFO-31 is a recently developed disease-
specific instrument derived from QUALEFFO-41 and
intended to have improved efficacy and response rates.
We aimed to validate QUALEFFO-31 in Chinese and
examine the use of QUALEFFO-31 in clinical practice.
This questionnaire was translated into Chinese and applied
to 118 case–control pairs aged between 50 and 85 years
with prevalent osteoporotic vertebral fractures to evaluate
its validity, repeatability, and discriminatory ability. It was
also used to evaluate the quality of life (QOL) of 69 case–
control trios with prevalent clinical and morphometric
fractures. The QOL of all subjects was concurrently
assessed using SF-36 for comparison. QUALEFFO-31
had good internal consistency with adequate convergent
and discriminatory validity. The median test–retest repeat-
ability ranged from 0.65–0.85. In general, there were good
correlations between QUALEFFO-31 and SF-36. ROC
curve analysis revealed that QUALEFFO-31 had significant
ability to discriminate between clinical fracture subjects
versus morphometric fracture subjects and controls.
QUALEFFO-31 also demonstrated higher discriminatory
capacity for pain. Subjects with clinical vertebral fractures
(CVFs) had a significant reduction in QOL compared with
other subjects. The QUALEFFO-31 is a useful tool for
assessing QOL in Chinese. It was well accepted and
significantly predictive of subjects with CVFs.
Keywords Chinese . Construct validation .
Health-related quality of life . Morphometric fracture .
Osteoporosis . QUALEFFO-31
Introduction
For the past few decades, osteoporosis has become a
growing public health concern worldwide associated with
aging of the world’s population [1]. It has been estimated
that 30–50% of women and 15–30% of men will suffer an
osteoporotic fracture in their lifetime [2]. The most
common clinical complications of osteoporosis are hip
fracture, vertebral deformity, and wrist fracture. Although
hip fractures are less prevalent in Asia than the USA [3, 4],
vertebral fractures are as frequent in Asian as in Caucasian
women [5]. Among Southern Chinese in Hong Kong, the
prevalence of vertebral fracture has been reported to be
17% in men and 30% in women [3, 6]. Vertebral fractures
can be classified as clinical (symptomatic) or morphometric
(radiographic) fractures. Both may be associated with
significant morbidity in terms of physical and psychosocial
functioning and reduce a subject’s health-related quality of
life (HRQoL) [7–12]. The concept of HRQoL refers to a
person or group’s perceived physical and mental health
over time. In recent years, a growing number of health care
professionals use HRQoL to estimate the burden of disease
in a population and to compare the consequences of
different diseases. Instruments that measure HRQoL are
thus an essential means by which to determine intervention
strategies and treatment outcomes in these patients.
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Generic or disease-specific instruments can be used to
assess HRQoL: traditionally, clinicians have relied on
generic instruments (such as the Short-Form 36, Sickness
Impact Profile, and the Nottingham Health Profile) in
subjects with vertebral fractures although such instruments
fail to explore the specific aspects of osteoporosis. Disease-
specific instruments for osteoporosis have therefore recent-
ly gained favor because they have greater face and content
validity for the individual disease. The Quality of Life
Questionnaire of the European Foundation for Osteoporosis
(QUALEFFO-41) is a well-established disease-specific tool
for assessing HRQoL in subjects with clinical [9] and
morphometric [13] vertebral fractures. At present, this
questionnaire has been translated into 20 languages and has
been found to be validated for use in other countries with
diverse cultures including Turkey [14] and Mexico [15].
QUALEFFO-41 consists of 41 questions in five domains
(pain, physical functioning, social functioning, general health
perception, and mental functioning). Nonetheless the large
number of items included in QUALEFFO-41 limited its
clinical application so QUALEFFO-31 was developed.
Derived from QUALEFFO-41, the shorter questionnaire that
comprised QUALEFFO-31 was intended to reap better
response rates and to be more efficacious in clinical practice.
Although QUALEFFO-31 [16] was derived by factor
analysis on a sound theoretical basis based on studies
conducted in Western populations, this new questionnaire
has yet to be validated and implemented in clinical practice
in Asian populations. To allow comparisons across countries,
we translated QUALEFFO-31 into Chinese and applied it to
a local population in Hong Kong in order to validate the
cross-cultural adaptation of the questionnaire for use in
Chinese populations. Therefore, the aims of this study were
[1] to assess the reliability and validity of QUALEFFO-31 in
Chinese populations in Hong Kong and [2] to investigate the
capacity of QUALEFFO-31C and SF-36 to differentiate
between subjects with clinical vertebral fractures and those
with morphometric fracture.
Methods
Subjects
Three groups of subjects were recruited: clinical fracture
cases, morphometric fracture cases, and controls. Subjects
presented clinically with low back pain to Queen Mary
Hospital and identified to have vertebral fractures on spine
X-ray were recruited as clinical fracture cases. Additional
inclusion criteria included age between 50 and 85 years,
presence of at least one vertebral fracture, i.e., >20%
reduction in vertebral height (anterior, middle, or posterior)
on spine X-ray, and possessing lumbar L1–4 spine bone
mineral density T-score <−1. Subjects had to be ambulant
and capable of completing the questionnaire. Subjects were
recruited into the study at least 6 months after their fracture
when they were considered to be stable. Patients with
fractures at other non-spine sites that interfered with pain or
activity and those with medical conditions that could affect
their activity of daily living and pain were excluded. Each
clinical fracture case was matched for sex and age (±3 years)
with one control subject who responded to advertisement
posted in the hospital. Control subjects with medical
conditions that exerted a major influence on the quality of
life were excluded from the study. Control subjects were
required to have no chronic low back pain, apparent
kyphosis, and no morphometric vertebral fractures as
defined by the previously stated criteria.
“Morphometric fracture cases” were defined as individ-
uals who displayed radiographic evidence of a vertebral
fracture according to Genant’s classification [17] in the
absence of clinical osteoporosis as defined above. These
were subjects referred to the Osteoporosis Centre for bone
mineral density assessment. Other inclusion and exclusion
criteria for this group of subjects were the same as before.
For comparison of HRQoL, each morphometric fracture
case was matched for sex and age (±3 years) with a clinical
fracture subject and two control subjects.
Informed consent was obtained from all study subjects
and demographic information collected at the baseline visit.
Approval was obtained from the Ethics Committee of The
University of Hong Kong and all procedures were
conducted in line with the terms of the Declaration of
Helsinki.
Questionnaires
The Chinese version of QUALEFFO-31 (QUALEFFO-31C)
was developed from the English version and translated into
Chinese. It was then translated back to English by blinded
individuals using standard procedures to confirm accuracy of
translation. The QUALEFFO-31C consists of three domains:
[1] pain, [2] physical function, and [3] mental function.
Response options are in the form of a five-point ordinal
scale, with lower scores indicating better quality of life. The
QUALEFFO provides both domain scores and an overall
score [9].
The Chinese version of the Short-Form 36 of the Medical
Outcome Study (SF-36), validated previously by Lam et al.
[18], was used as a reference for comparison with
QUALEFFO-31C questionnaires. The Chinese version of
the Short-Form 36 covers eight multi-item scales: physical
functioning, limitations due to physical health problems,
bodily pain, general health, vitality, social functioning,
limitations due to emotional health problems, mental
health, and one single-item scale on health transition.
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Questionnaires were administered to subjects (both cases
and controls) in Cantonese, the language for Southern
Chinese in Hong Kong, at the Osteoporosis Clinic of Queen
Mary Hospital before any investigative procedures were
performed. Both questionnaires were completed by interview
of the subject. The questionnaires were subsequently
administered again to the same subjects after 4 weeks. All
inter-current events between the two visits were noted.
Radiographic assessment
Standardized lateral radiographs of the thoracic and lumbar
vertebrae (T4–L5) were taken and assessed by experienced
radiologists to identify vertebral deformities according to
Genant’s classification [17].
Statistical analysis
Statistical analysis was based on the protocol used by Lips
et al. in the validation study of QUALEFFO-41 [9]. The
scoring algorithm provided by the International Osteoporo-
sis Foundation for the QUALEFFO was used. A lower
score indicates better quality of life. All questions were
scored from 1 to 5 except for questions 16, 17, and 18 in
the physical function domain, in which appropriate adjust-
ments were made according to the scoring algorithm
(questions 16 and 17 were equivalent to questions 24 and
26 in QUALEFFO-41 and were scored from 1–3, question
18 was equivalent to question 27 in QUALEFFO-41 and
was scored from 1–4). For questions 16 and 17, the answers
“not applicable” and “no cinema or theater within reason-
able distance” were not scored. Questions 2, 3, 4, 6, 8, and
9 of the mental function domain (equivalent to questions,
33, 34, 35, 37, 39, and 40 in QUALEFFO-41) were
reversed so that all scores were coded from healthiest [1] to
least healthy [5]. Individual domain scores were calculated
by summation of the scores of all the questions within that
domain followed by linear transformation to a scale of 100,
where 0 represented poor health and 100 represented good
health. Floor and ceiling effects were assessed by calculat-
ing the percentage of subjects with the lowest and highest
possible domain scores, respectively. This was used to
confirm that the answer scale was adequate for the study
population. Convergent and discriminant validity were used
to assess the adequacy of score construction. Convergent
validity was considered adequate if the correlation coeffi-
cient between each question with its own total domain
score was >0.40. Discriminant validity was considered
adequate if the correlation of the score of each question
with its total domain score was higher than that of the total
scores of other domains. Internal consistency was assessed
using Cronbach’s α. The closer the Cronbach’s α is to 1,
the higher the proportion of variance is to zero. Test–
retest repeatability was assessed by weighted kappa
statistics.
Scores on SF-36 were calculated according to the
standard scoring algorithm. Correlation between scores of
similar domains of QUALEFFO-31C and SF-36 were
analyzed. For comparison, scores were standardized such
that higher scores indicated greatest impact on health (i.e.,
worse health). All statistical analyses were performed using
SPSS for Windows version 15.0 statistical software (SPSS,
Chicago, IL, USA). Receiver operating characteristics (ROC)
curves were established to compare the ability of QUAL-
EFFO and SF-36 domains as well as total and composite
scores to discriminate between cases and controls over all
possible cut-off values of the questionnaire. ROC curve
analysis was conducted using MedCalc package version 9.3
(MedCalc, Mariakerke, Belgium).
Results
Subjects
For the validation study, 118 clinical fracture case–control
pairs were recruited. The mean age for the clinical fracture
group and control group was 63.7 (SD 6.6) and 63.4 (SD
6.8) years, respectively. The ratio of men to women was
approximately 1:3. For the morphometric fracture QOL
study, 68 morphometric fracture case–control quadruples
(each morphometric fracture case was matched to one
clinical fracture case and two controls) were included in the
study. The mean age of the morphometric, clinical fracture
and control subjects was 65.8 (SD 7.8), 65.4 (SD 7.4), and
65.3 (SD 7.4) years, respectively.
Validation of the structure of QUALEFFO-31C
The results of the multi-trait analysis of the QUALEFFO-
31C grouped according to three main domains—pain,
physical function, and mental function—are shown in
Table 1. In our study, 27 out of 31 questions demonstrated
satisfactory convergent validity (i.e., item-associated domain
score correlation coefficient >0.40). The item-associated
domain score correlation coefficient ranged from 0.72–0.93
for questions in the pain domain, 0.26–0.74 for the physical
functioning domain, and 0.46–0.68 for the mental function-
ing domain. For discriminatory validity, all questions within
QUALEFFO-31C demonstrated higher correlation coeffi-
cients between item-associated domain total score than item-
unassociated domain total scores: pain domain, physical
function domain, and mental function domain. In addition,
the response rate was very high with a range of 99.2–100%.
The median kappa scores for test–retest repeatability ranged
from 0.65–0.85. Of the 31 questions, 23 questions (74%) had
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kappa values >0.7. The internal consistency ranged from
0.72–0.87 (i.e., Cronbach’s α >0.70).
Comparison of domain, total, and composite scores
between clinical vertebral fracture cases and controls
using QUALEFFO-31C and SF-36
The mean scores on QUALEFFO-31C and SF-36 for clinical
vertebral fracture cases and controls are shown in Table 2.
Subjects with clinical osteoporotic vertebral fractures showed
significant impairment of HRQoL on the QUALEFFO-31C
compared with age- and sex-matched controls. Similar results
were also observed using the SF-36. All corresponding
domain scores and the physical composite score showed
significant impairment of QOL in clinical fracture cases
relative to controls. Despite the results for the mental health
domain (p=0.04), the mental composite summary score on
SF-36 did not show a significant difference between clinical
fracture cases and controls (p=0.053).
Spearman rank correlation coefficients between scores
of similar domains of QUALEFFO-31C and SF-36
instruments
Spearman correlation coefficients between corresponding
domains on the two scales are shown in Table 3. The
correlation between corresponding domains of QUALEFFO-
31C and SF-36 was good, implying that they were directly
comparable. The total QUALEFFO-31C score also correlat-
ed well with the SF-36 physical composite score (r2=0.67,
p<0.001).
ROC curve analysis
The discriminatory capacity of each of the domains of
QUALEFFO-31C and SF-36 (as demonstrated by the area
under the ROC curve) is shown in Table 4. Table 4
demonstrates that the pain domain had the highest
discriminatory capacity on both instruments, followed by
physical functioning, then mental functioning domains. The
QUALEFFO-31C total score and SF-36 physical composite
summary score had similar discriminatory capacities. The
mental composite summary score of SF-36 nonetheless had
poor discriminatory capacity to differentiate between the
two groups of subjects. All domains, total score, and
composite summary score of the QUALEFFO-31C were
discriminatory between clinical fractures and controls
subjects. For the SF-36, the mental composite score was
not discriminatory between clinical fracture subjects and
controls, but all other relevant domain and composite scores
were.
Quality of life in subjects with morphometric fractures
The mean scores for various domains on QUALEFFO-31
and SF-36 for subjects with morphometric fractures and
Table 1 Results of multi-trait analysis of QUALEFFO-31
Domain (no.
of question)
Convergent
validity (%)
Item convergent validity
range of correlations
Discriminant
validity (%)
Response rate Repeatability Internal consistency
Median (range) Median (range) Cronbach’s α
Pain [4] 100 0.72–0.93 100 100 (99.2–100) 0.85 (0.83–0.87) 0.87
Physical function [18] 78 0.26–0.74 100 100 (99.2–100) 0.85 (0.34–0.97) 0.83
Mental function [9] 100 0.46–0.68 100 100 (99.4–100) 0.65 (0.40–0.78) 0.72
Domain Control Clinical p value
Mean (SD) Mean (SD)
QUALEFFO
Pain 0.9 (4.7) 33.6 (23.5) <0.001
Physical function 6.8 (7.0) 12.2 (10.8) <0.001
Mental function 33.3 (13.3) 37.3 (15.3) 0.035
QUALEFFO-31C total score 15.2 (7.4) 22.8 (10.3) <0.001
QUALEFFO-31C pain + physical composite score 3.8 (4.6) 22.9 (14.6) <0.001
SF-36
Bodily pain 85.4 (18.7) 62.6 (22.6) <0.001
Physical health 82.1 (17.5) 72.3 (21.4) <0.001
Mental health 76.9 (14.3) 70.4 (18.3) 0.04
Physical composite summary score 14.2 (1.5) 13.0 (1.8) <0.001
Mental composite summary score 27.8 (1.3) 27.4 (1.6) 0.053
Table 2 Scores of QUALEFFO-
31C domains in control subjects
vs clinical fracture subjects
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their comparison with control and clinical fracture subjects
are shown in Table 5. Compared with subjects with clinical
fractures, those with morphometric fractures reported a
better quality of life in terms of pain and physical
functioning (as seen from the respective domain scores on
both instruments, the QUALEFFO-31 total score, the
QUALEFFO-31 pain plus physical composite scores, and
the SF-36 physical composite score). Compared with
controls, subjects with morphometric fractures did not
show any significant difference in HRQoL. Table 6 showed
similar results as Table 5.
Discussion
QUALEFFO is a disease-specific instrument to assess
common life problems faced by patients with osteoporotic
vertebral fractures. Although QUALEFFO-31C had not
been previously validated in Chinese, the response rate was
high in the present study (i.e., 100% for all QUALEFFO
domains). QUALEFFO-31C also demonstrated good short-
term reproducibility after 4 weeks and was well accepted by
our population, as shown by the high kappa scores from the
test–retest reproducibility analysis. The coefficient of
internal consistency (Cronbach’s α) of all domains was
>0.70. Our results were similar to that of a previous
study by Lips et al. [9] in which 26 out of 41 (i.e., 63%)
questions had kappa scores ≥0.70. In this study, the
Cronbach’s α for the mental functioning domain was
generally lower than that of the other two domains (i.e.,
pain and physical function). These Cronbach’s α values
were similar to those found in previous validation studies
for both QUALEFFO-41 [9] and QUALEFFO-31 [16].
These findings suggest that QUALEFFO is easy to
understand and that both controls and subjects with
vertebral fractures can complete the questionnaire without
major difficulties.
The original instrument (QUALEFFO-41) contained 41
questions in five domains (pain, physical functioning,
mental functioning, general health perception, and social
functioning). This has been reduced to 31 questions in three
domains (pain, physical functioning, and mental function-
ing) in QUALEFFO-31. Questions from the two deleted
domains were either reclassified or deleted depending on
their contribution to the overall assessment. For example,
questions 3 and 4 from QUALEFFO-41 were combined to
make the assessment more comprehensive (i.e., producing
question 3 in QUALEFFO-31) [16]. Multi-trait analysis
revealed that the score construction of the new question-
naire was sufficient. This was to be expected, as the Likert
scale inherited from its parent instrument was unchanged.
Adequate convergent and discriminant validity was seen,
indicating that questions related to the same concept had
roughly equal variance, which in turn implied that weighing
Table 3 Spearman rank correlation between scores of similar domains of QUALEFFO-31C and SF-36 instruments
QUALEFFO domain SF-36 domain Correlation coefficient p value
Pain Bodily pain 0.56 <0.001
Physical function Physical functioning 0.72 <0.001
Mental function Mental health 0.63 <0.001
QUALEFFO-31C total score Physical composite score 0.67 <0.001
QUALEFFO-31C total score Mental composite summary score 0.38 <0.001
QUALEFFO-31C pain + physical composite score Physical composite summary score 0.62 <0.001
Table 4 Area under ROC in clinical fracture vs. control groups
Domain QUALEFFO-31C
(SE)a
SF-36
(SE)a
Difference in
area (SE)
p value
Pain 0.91 (0.02) 0.79 (0.03) 0.12 <0.001
Physical function 0.69 (0.03) 0.66 (0.03) 0.03 0.249
Mental function 0.59 (0.04) 0.62 (0.04) −0.03 0.202
QUALEFFO total score vs. SF-36 physical composite summary score 0.75 (0.03) 0.71 (0.03) 0.04 0.425
QUALEFFO total score vs. SF-36 mental composite summary score 0.75 (0.03) 0.55 (0.04) 0.20 <0.001
QUALEFFO pain and physical composite score vs. SF-36 physical
composite summary score
0.91 (0.02) 0.71 (0.03) 0.20 <0.001
QUALEFFO mental score vs. SF-36 mental composite summary score 0.59 (0.03) 0.55 (0.04) 0.04 0.051
a All domain and composite score were discriminatory between clinical fracture subjects and controls except for the SF-36 mental composite summary score
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of questions was unnecessary [9]. A small number of
questions in the physical function domain did not show a
correlation coefficient >0.40 with the physical function
domain score. This was nonetheless anticipated as the study
by Lips et al. [9] also noted that some of their questions
within the physical function domain did not demonstrate
adequate convergent validity. One of our questions in
particular had a low correlation coefficient with the
physical domain score (0.26). This was in accordance with
the findings of a Turkish study [14] that showed similar
correlation coefficients (0.27) in some of its questions in its
version of QUALEFFO-41. The reason for inadequate
convergent validity has not been explained in the published
literature for QUALEFFO. We are uncertain about the
cause of this phenomenon in our own study, but we believe
that cultural and environmental factors are involved as this
phenomenon tends to occur in different questions among
different culture populations.
From ROC curve analyses, all domain and composite
summary scores from QUALEFFO-31C were able to
discriminate between clinical fracture subjects and age-
matched controls. The “pain domain score” and “pain and
physical composite summary score” displayed particularly
strong ability to discriminate between the two study groups.
When compared with the corresponding scores on the
QUALEFFO-31C, the bodily pain and physical health
domain scores of SF-36 showed comparable discriminatory
capability. In addition, the QUALEFFO-31 total score had
similar discriminatory capability to the SF-36 physical
composite score. This is consistent with the results of
previous studies using QUALEFFO-41 [9]. Our results
showed that it had better discriminatory capability than the
SF-36 mental composite score. The QUALEFFO-31 pain
and physical composite score also discriminated well
between clinical fracture subjects and controls, better than
the SF-36 physical composite score.
Table 5 Scores of QUALEFFO-31C domains in morphometric fracture subjects vs. clinical fracture subjects and vs. control subjects
Morphometric
(n=69)
Clinical
(n=69)
Control
(n=133)
Morphometric vs
clinical fracture
Morphometric vs
control
Mean (SD) Mean (SD) Mean (SD) p value p value
QUALEFFO
Pain 0.9 (5.4) 35.2 (25.1) 0.9 (4.8) <0.001 1.000
Physical function 8.0 (10.2) 14.0 (11.0) 6.5 (7.0) <0.001 0.840
Mental function 34.5 (15.9) 38.6 (15.8) 33.1 (12.9) 0.289 1.000
QUALEFFO-31C total score 16.5 (9.8) 24.5 (10.6) 15.0 (7.2) <0.001 0.777
QUALEFFO-31C pain +
physical composite score
4.5 (5.9) 24.6 (15.0) 3.7 (4.6) <0.001 1.000
SF-36
Bodily pain 82.5 (22.8) 61.7 (21.2) 86.2 (18.5) <0.001 0.721
Physical health 81.5 (17.8) 67.6 (23.0) 83.8 (16.5) <0.001 1.000
Mental health 75.2 (15.4) 67.2 (17.9) 77.4 (14.3) 0.009 1.000
Physical composite summary score 14.1 (1.5) 12.7 (1.9) 14.3 (1.4) <0.001 1.000
Mental composite summary score 27.7 (1.4) 27.2 (1.6) 27.8 (1.3) 0.278 1.000
Results obtained using ANOVA with Bonferroni adjustment. Subjects matched for sex, age ±3 years
Table 6 Area under ROC in morphometric fracture vs. clinical fracture groups
Domain QUALEFFO-31C
(SE)a
SF-36
(SE)a
Difference in
area (SE)
p value
Pain 0.90 (0.03) 0.75 (0.04) 0.15 <0.001
Physical function 0.72 (0.05) 0.72 (0.04) 0.00 0.181
Mental function 0.58 (0.05) 0.66 (0.04) −0.08 0.148
QUALEFFO total score vs. SF-36 physical composite summary score 0.75 (0.04) 0.73 (0.04) 0.02 0.456
QUALEFFO total score vs. SF-36 mental composite summary score 0.75 (0.04) 0.57 (0.04) 0.20 <0.001
QUALEFFO pain and physical composite score vs. SF-36 physical
composite summary score
0.90 (0.03) 0.73 (0.04) 0.17 <0.001
QUALEFFO mental score vs. SF-36 mental composite summary score 0.58 (0.04) 0.57 (0.04) 0.01 0.458
a All domain and composite score were discriminatory between morphometric fracture subjects and clinical fracture subjects except for the SF-36 mental
composite score
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Our study showed that Chinese subjects with clinical
vertebral fractures suffer significant impairment in QOL
compared with age and sex-matched control subjects. This
was consistent with previous studies in which pain,
physical, and mental functioning were all impaired. This
was also apparent during our assessment using both
instruments. Also consistent with previous studies was that
QUALEFFO was better able to assess pain—an area known
to be more seriously affected in subjects with osteoporosis.
Assessment of mental functioning domains and mental
composite scores had poor discriminatory power on both
scales. This was again in line with the findings of the first
validation study of QUALEFFO by Lips et al. [9] and
subsequently confirmed by reports comparing QUALEFFO
with SF-36 [19].
Further analyses demonstrated that the QUALEFFO-31
was able to discriminate well between morphometric
subjects and clinical subjects in terms of pain and physical
functioning. The total QUALEFFO-31 score, pain plus
physical composite score were also useful discriminatory
tools between these two groups. Similar results were
obtained for various corresponding domains of SF-36. Like
the results for clinical fractures vs. controls, the QUALEFFO-
31 was superior in discriminating between clinical vs.
morphometric fracture subjects in terms of pain compared
with SF-36. In all other areas the two instruments had similar
discriminatory ability. Results from the study also demon-
strated that there was no significant difference in the quality of
life between subjects with morphometric fractures and
controls. Previous studies have shown that subjects with
incident morphometric fractures had increased back pain and
reduced physical functioning; nonetheless, those with preva-
lent morphometric fractures only, regardless of degree, did not
show any significant results. Our results were consistent with
the latter studies.
There were several limitations to the present study. First,
responsiveness of QUALEFFO to incident fracture and the
relationship between the number of fractures and the
QUALEFFO-31 domain scores was not investigated. We
had not followed the patients over a period of time for
fracture outcome to evaluate whether there is any change in
the scores. Previous studies reveal that QUALEFFO-41 did
not have a significant relationship with the number of
fractures; nonetheless, the preliminary study of QUALEFFO-
31 showed ability to differentiate between those with only one
fracture versus those with more than one vertebral fracture. As
this study lacks long-term follow-up, and to avoid erroneous
conclusions from subject’s recall of vertebral fracture history
we have not attempted to determine whether a similar
relationship exists for QUALEFFO-31C compared with the
English version. A longitudinal study would be helpful to
validate this instrument in our population. Second, the main
aim of our study was to validate the Chinese version of
QUALEFFO-31. Cognitive debriefing had not been carried out
to ascertain the understanding, interpretation, and relevance
of the content of the questionnaire in our culture. It is likely
that some items are not fully applicable to our population,
which might explain the low Cronbach’s alpha in some
domains. Besides, the QOL of incident fractures (both
morphometric and clinical) and the QOL of subjects after
medical/surgical treatment were not investigated in this
study. These are interesting topics that may prove helpful
if investigated.
Conclusions
In conclusion, quality of life is impaired in subjects with
vertebral fractures due to osteoporosis when compared with
controls. This study also demonstrated that the Chinese
version of QUALEFFO-31 is a reliable, repeatable, consis-
tent, coherent tool that discriminates well between clinical
fracture subjects and controls, particularly in terms of pain
and physical function. However, the Cronbach’s α results
suggest that further refinement in specific areas of the
Chinese version of QUALEFFO-31 is required, especially
in the mental functioning domain. Taken together, this new
shortened form of QUALEFFO reduces redundancy of
questions and effectively assesses health-related quality of
life for subjects with clinical vertebral fractures. The
findings will be useful for the determination of cost-
effective threshold cut-off for Chinese in the future.
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